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TO THE EDITOR: We recently published a study investigating the
bronchodilatory capacity of the Toll-like receptor 7 (TLR7)
agonist imiquimod, establishing the presence of a nonneuronal,
TLR7-independent mechanism of dilation (9). Our study adds
new information to the previously published reports, which
demonstrated that relaxation can be mediated by a TLR7-
dependent release of nitric oxide (NO) from innervating nerves
(2, 5). In a Letter to the Editor, Drake (2a) now argues that the
data we report do not provide sufficient evidence to support our
conclusion of a nonneuronal TLR7-independent mechanism.
We would instead argue that our results are sound and reflect
the presence of an additional mechanism for imiquimod-me-
diated bronchodilation.
In our study, we demonstrated that administration of the
neurotoxin tetrodotoxin (TTX) in vitro had no effect on imi-
quimod-induced bronchodilation and thus concluded that neu-
ronal pathways were not involved in dilation (9). Due to the
presence of TTX-resistant nerves, particularly those originat-
ing from the nodose ganglia (8), Drake suggests that this is not
sufficient to discount neuronal involvement. However, the
contribution of TTX-resistant nodose-derived sensory nerves
to relaxation is unlikely. Although these nerves contain relax-
atory mediators, namely pituitary adenylate cyclase-activating
polypeptide (PACAP) (1, 3) and substance P (SP) (4, 12), SP
induces relaxation via the epithelium (4) and PACAP relaxes
independently of nitric oxide synthase (NOS) (7). This argues
against Drake’s proposed mechanism of epithelium-indepen-
dent and NO-mediated relaxation. In addition, activation of
sensory neurons by imiquimod has been shown to be TLR7
independent (6), which suggests that a TLR7-dependent neu-
ronal mechanism of relaxation does not occur via sensory
neurons. We could further demonstrate in our study that all
nerve-mediated relaxation was blocked by TTX (9). NO-
releasing inhibitory nonadrenergic, noncholinergic (iNANC)
fibers have repeatedly been shown to be TTX sensitive (10),
suggesting that our use of TTX was sufficient to evaluate and
discount the possible contribution of NO-mediated neuronal
relaxation, the mechanism proposed by Drake and colleagues.
Noticeably, there are discrepancies between our results and
those published previously by Drake and colleagues, particu-
larly from experiments assessing the roles of TLR7 and NO,
using the interventions IRS661 and NG-nitro-L-arginine methyl
ester (L-NAME)/NG-monomethyl-L-arginine (L-NMMA), re-
spectively. Using the same concentration of IRS661 as previ-
ously used in vitro (5), we were unable to see any effect on
imiquimod-induced bronchodilation. Although we did not con-
firm the ability for IRS661 to inhibit TLR7 in this study, we
have previously confirmed its ability to inhibit TLR7-mediated
responses in isolated airway smooth muscle cells (11). In
addition, we showed that the TLR7 agonist CL264 failed to
induce relaxation or inhibit histamine-induced Ca2 flux,
which would dispute a role for TLR7. The discrepancy be-
tween our and Drake and colleagues’ in vitro L-NMMA or
IRS661 results may be related to the dissection technique,
which can affect the extent of neuronal innervation. Indeed, the
fact that we identified a small role for NO in vivo, as high-
lighted by Drake, could suggest that the relative presence or
absence of intact nerves is of importance in identifying a
neuronal TLR7-dependent mechanism for dilation.
We would like to reiterate that our study does not dispute
that of Drake and colleagues but purely supplies an additional
mechanism for imiquimod-mediated bronchodilation. Using a
nerve-free setup with isolated airway smooth muscle, we
identified that imiquimod could additionally directly influence
histamine-induced Ca2 flux in smooth muscle cells in a
TLR7-independent manner. In addition, as shown previously
by Drake and colleagues (5), inhibition of NO or TLR7 does
not fully reverse the dilatory effects of imiquimod, suggesting
that another mechanism feasibly exists. The relative contribu-
tion of respective mechanisms may be dependent on the model
used, the route of administration of imiquimod, and the relative
presence of neuronal innervation. The complexity of imi-
quimod-mediated bronchodilation is fascinating and is likely to
be of use in the development of novel fast-acting, bronchodi-
latory compounds.
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